SCHEMBL26291598

SCHEMBL26291598

C=CC(=O)OCOc1ccc2cc(-c3cccn3C)oc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 1/20 0.36
▸ S1PR3 Q99500 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ ALDH1A1 P00352 5/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ APP P05067 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ F2RL3 Q96RI0 3/20 0.35
▸ MAPT P10636 3/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ HPGD P15428 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26291600 0.85 RAB9A (0.37) S1PR1S1PR3CA9ALDH1A1RAB9A
SCHEMBL26291464 0.81 HDAC6 (0.47) S1PR1S1PR3CA12CA1CA9
SCHEMBL26292135 0.81 RAB9A (0.38) S1PR1S1PR3CA12CA1CA9
SCHEMBL23395493 0.79 SRD5A1 (0.32) ALDH1A1F2RL3KDM4EHPGDMKNK1
SCHEMBL26291461 0.78 RAB9A (0.40) S1PR1S1PR3CA12CA1CA9
SCHEMBL26291596 0.78 S1PR1 (0.41) S1PR1S1PR3CA12CA1CA9
SCHEMBL26291480 0.77 PTPN1 (0.47) ALDH1A1RAB9AAPPNPC1MAOB
SCHEMBL23395566 0.76 PTPN1 (0.48) CA12CA1CA9ALDH1A1RAB9A
SCHEMBL26291477 0.75 PTPN1 (0.47) CA12CA9ALDH1A1RAB9AAPP
SCHEMBL26291539 0.75 PTPN1 (0.58) S1PR1CA12CA9ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D S1PR1 3832/4885S1PR3 2612/4885CA12 3042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback